相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort
Torsten Pietsch et al.
ACTA NEUROPATHOLOGICA (2014)
ACR Appropriateness Criteria® W Pediatric Hodgkin Lymphoma
Stephanie A. Terezakis et al.
PEDIATRIC BLOOD & CANCER (2014)
De-escalation of Therapy for Pediatric Medulloblastoma: Trade-Offs Between Quality of Life and Survival
Natalie Henrich et al.
PEDIATRIC BLOOD & CANCER (2014)
DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies
Edward C. Schwalbe et al.
ACTA NEUROPATHOLOGICA (2013)
Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays
Volker Hovestadt et al.
ACTA NEUROPATHOLOGICA (2013)
Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples
Paul A. Northcott et al.
ACTA NEUROPATHOLOGICA (2012)
Molecular subgroups of medulloblastoma: the current consensus
Michael D. Taylor et al.
ACTA NEUROPATHOLOGICA (2012)
Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations
Trevor J. Pugh et al.
NATURE (2012)
Novel mutations target distinct subgroups of medulloblastoma
Giles Robinson et al.
NATURE (2012)
Dissecting the genomic complexity underlying medulloblastoma
David T. W. Jones et al.
NATURE (2012)
Subgroup-specific structural variation across 1,000 medulloblastoma genomes
Paul A. Northcott et al.
NATURE (2012)
Molecular inversion probes: a novel microarray technology and its application in cancer research
Yuker Wang et al.
CANCER GENETICS (2012)
Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups
David W. Ellison et al.
ACTA NEUROPATHOLOGICA (2011)
Rapid Diagnosis of Medulloblastoma Molecular Subgroups
Ed C. Schwalbe et al.
CLINICAL CANCER RESEARCH (2011)
Definition of Disease-Risk Stratification Groups in Childhood Medulloblastoma Using Combined Clinical, Pathologic, and Molecular Variables
David W. Ellison et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Medulloblastoma Comprises Four Distinct Molecular Variants
Paul A. Northcott et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Beta-catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics
Sarah Fattet et al.
JOURNAL OF PATHOLOGY (2009)
Mutations of the Wnt antagonist AXIN2 (Conductin) result in TCF-dependent transcription in medulloblastomas
Arend Koch et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis
Steven C. Clifford et al.
CELL CYCLE (2006)
Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial
Amar Gajjar et al.
LANCET ONCOLOGY (2006)
β-catenin status predicts a favorable outcome in childhood medulloblastoma:: The United Kingdom Children's Cancer Study Group Brain Tumour Committee
DW Ellison et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
AXIN1 mutations but not deletions in cerebellar medulloblastomas
N Baeza et al.
ONCOGENE (2003)
Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification
JP Schouten et al.
NUCLEIC ACIDS RESEARCH (2002)
Somatic mutations of WNT/wingless signaling pathway components in primitive neuroectodermal tumors
A Koch et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Nuclear localization and mutation of β-catenin in medulloblastomas
CG Eberhart et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2000)
APC mutations in sporadic medulloblastomas
HT Huang et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
分享论文
